Uncategorized Archives - Page 7 of 26 - Rapid Dose Therapeutics

Latest News

July 28, 2022
Rapid Dose Therapeutics Provides Bi-Weekly MCTO Status Update

View News Release View PDF

July 13, 2022
Rapid Dose Therapeutics Provides Bi-Weekly MCTO Status Update

View News Release View PDF

June 30, 2022
Rapid Dose Therapeutics Announces Issuance of Management Cease Trade Order

View News Release View PDF

June 16, 2022
Rapid Dose Therapeutics Announces Delay in Filing Annual Financial Statements

View News Release View PDF

May 26, 2022
Rapid Dose Therapeutics Corp Announces Proposed Private Placement

View News Release View PDF

May 25, 2022
Rapid Dose Therapeutics Closes First Tranche of Private Placement

View News Release View PDF

May 12, 2022
Rapid Dose Therapeutics Provides Shareholder Update Regarding Vaccine Collaboration Agreement with Oakland Health Limited in the United Kingdom

View News Release View PDF

April 26, 2022
Rapid Dose Therapeutics and Skycare Compounding Labs to Provide Patients with a Novel Oral Delivery Option for Pharmaceutical Products

View News Release View PDF

March 7, 2022
RD Therapeutics and Rapid Dose Therapeutics Participate in the CEPI Global Pandemic Preparedness Summit and Support the #100DaysMission — the value of needle-free vaccination, such as the QuickStrip™, will be discussed.

View News Release View PDF

February 10, 2022
Rapid Dose Therapeutics Announces Management Change

View News Release View PDF